Kyverna Therapeutics, Inc. (KYTX)

Kyverna Therapeutics Market Cap

Kyverna Therapeutics has a market cap or net worth of $666.99 million as of April 26, 2024.

• Market Cap: 666.99M
• Enterprise Value: 617.96M
• 1-Year Change: n/a
• Ranking: #2727
• Category: Small-Cap
• Stock Price: $15.47

Market Cap Chart

Since the IPO on February 8, 2024, Kyverna Therapeutics's market cap has decreased from $898.10M to $666.99M, a decrease of -25.73%.

Market Cap History

Date	Market Cap	% Change
Apr 26, 2024	667.00M	-2.95%
Apr 25, 2024	687.30M	-9.99%
Apr 24, 2024	763.60M	-7.71%
Apr 23, 2024	827.40M	-1.58%
Apr 22, 2024	840.70M	7.14%
Apr 19, 2024	784.70M	-4.26%
Apr 18, 2024	819.60M	-6.95%
Apr 17, 2024	880.80M	-8.92%
Apr 16, 2024	967.10M	-2.01%
Apr 15, 2024	986.90M	0.48%
Apr 12, 2024	982.20M	-4.64%
Apr 11, 2024	1.03B	-3.17%
Apr 10, 2024	1.06B	0.33%
Apr 9, 2024	1.06B	5.63%
Apr 8, 2024	1.00B	4.77%
Apr 5, 2024	958.00M	-0.36%
Apr 4, 2024	961.50M	1.74%
Apr 3, 2024	945.10M	-4.27%
Apr 2, 2024	987.30M	1.68%
Apr 1, 2024	971.00M	-9.34%
Mar 28, 2024	1.07B	3.03%
Mar 27, 2024	1.04B	-3.01%
Mar 26, 2024	1.07B	12.98%
Mar 25, 2024	948.70M	-9.65%
Mar 22, 2024	1.05B	-4.38%

View and export this data all the way back to 2024. Sign Up Today.

Related Stocks

Company	Market Cap
Atrion	695.20M
enGene Holdings	683.56M
Varex Imaging	681.67M
Disc Medicine	679.96M
Pharming Group	678.49M
Stoke Therapeutics	646.78M
Y-mAbs Therapeutics	643.96M
Treace Medical Concepts	642.25M